Influence of terminal branching on the transdermal permeation-enhancing activity in fatty alcohols and acids

Bioorganic and Medicinal Chemistry

Volumn 14, Issue 23, 2006, Pages 7681-7687

  Klimentová, Jana ^a   Kosák, Petr ^a   Vávrová, Kateřina ^a   Holas, Tomáš ^a   Hrabálek, Alexandr ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Enhancers; Isoacids; Isoalcohols; Percutaneous; Skin; Theophylline

Indexed keywords

FATTY ACID; FATTY ALCOHOL; METHYL GROUP; PENETRATION ENHANCING AGENT; THEOPHYLLINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CORRELATION ANALYSIS; IN VITRO STUDY; NONHUMAN; SKIN PERMEABILITY;

ANIMALS; FATTY ACIDS; FATTY ALCOHOLS; MODELS, BIOLOGICAL; PERMEABILITY; SKIN; STRUCTURE-ACTIVITY RELATIONSHIP; SWINE; THEOPHYLLINE;

SUIDAE;

EID: 33750040565     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2006.08.013     Document Type: Article

References (37)

1. Suhonen T.M., Bouwstra J.A., and Urtti A. J. Controlled Release 59 (1999) 149
2. Berner B., and Liu P. In: Smith E.W., and Maibach H.I. (Eds). Percutaneous Penetration Enhancers (1995), CRC Press, Boca Raton, Florida 45-46
3. Aungst B.J. In: Smith E.W., and Maibach H.I. (Eds). Percutaneous Penetration Enhancers (1995), CRC Press, Boca Raton, Florida 277-287
4. Aungst B.J. Pharm. Res. 6 (1989) 244
5. Andega S., Kanikkannan N., and Singh M. J. Controlled Release 77 (2001) 17
6. Sloan K.B., Beall H.D., Taylor H.E., Getz J.J., Villaneuva R., Nipper R., and Smith K. Int. J. Pharm. 171 (1998) 185
7. Kadir R., Stempler D., Liron Z., and Cohen S. J. Pharm. Sci. 76 (1987) 774
8. Chantasart D., Li S.K., He N., Warner K.S., Prakongpan S., and Higuchi W.I. J. Pharm. Sci. 93 (2004) 762
9. Hrabálek A., Vávrová K., Doležal P., and Macháček M. J. Pharm. Sci. 94 (2005) 1494
10. Gunstone F.D. Chem. Phys. Lipids 65 (1993) 155
11. Marzouki Z.M.H., Taha A.M., and Gomaa K.S. J. Chromatogr. B 425 (1988) 11
12. Williams A.C., and Barry B.W. Adv. Drug Delivery Rev. 56 (2004) 603
13. Schneider I.M., Dobner B., Neubert R., and Wohlrab W. Int. J. Pharm. 145 (1996) 187
14. Zacharkin L.I., Čurilova I.M., and Anikina E.V. Russ. J. Org. Chem. 24 (1988) 77
15. Yuasa Y., and Tsuruta H. Flavour Frag. J. 19 (2004) 199
16. Hassarajani S.A., Mithran S., and Mamdapur V.R. J. Chem. Res., Synop. 6 (1993) 219
17. Heyne H.W., and Jones H. J. Am. Chem. Soc. 73 (1951) 1361
18. Pattison F.L.M., Stothers J.B., and Woolford R.G. J. Am. Chem. Soc. 78 (1956) 2255
19. Fang J.Y., Tsai T.H., Hung C.F., and Wong W.W. J. Pharm. Pharmacol. 56 (2004) 1493
20. Sznitowska M., Janicki S., and Williams A. J. Pharm. Sci. 87 (1998) 1109
21. Heard C.M., Johnson S., Moss G., and Thomas C.P. Int. J. Pharm. 317 (2006) 26
22. Vávrová K., Hrabálek A., Doležal P., Šámalová L., Palát K., Zbytovská J., Holas T., and Klimentová J. Bioorg. Med. Chem. 11 (2003) 5381
23. Hrabálek A., Doležal P., Vávrová K., Zbytovská J., Holas T., Klimentová J., and Novotný J. Pharm. Res. 23 (2006) 912
24. Holas T., Vávrová K., Klimentová J., and Hrabálek A. Bioorg. Med. Chem. 14 (2006) 2896
25. Kanikkannan N., Kandimala K., Lamba S.S., and Singh M. Curr. Med. Chem. 7 (2000) 593
26. Vávrová K., Zbytovská J., and Hrabálek A. Curr. Med. Chem. 12 (2005) 2273
27. Log P values were calculated using ChemDraw Ultra 10.0 software (CambridgeSoft, USA).
28. Murakami Y., Nakano A., and Ikeda H. J. Org. Chem. 47 (1982) 2137
29. Chuit P., and Hausser J. Helv. Chim. Acta 12 (1929) 463
30. Cason J. J. Am. Chem. Soc. 64 (1942) 1106
31. Hassarajani S.A., Mithran S., and Mamdapur V.R. Indian J. Chem. B: Org. Chem. Incl. Med. Chem. B (1995) 429
32. Weitzel G., Wojahn J., and Hoppe-Seyler's Z. Physiol. Chem. 287 (1951) 65
33. Milburn A.H., and Truter E.V. J. Chem. Soc. (1954) 3344
34. Cason J., and Stanley W.L. J. Org. Chem. 14 (1949) 137
35. Levene P.A., and Allen C.H. J. Biol. Chem. 27 (1916) 433
36. Hougen F.W., Ilse D., Sutton D.A., and de Villiers J.P. J. Chem. Soc. Abstr. (1953) 98
37. Weitkamp A.W. J. Am. Chem. Soc. 67 (1945) 447